“Thrombosis in 25 cases out of 20 million, Covid is much more dangerous” – time.news

by time news

There are 25 recorded cases of thrombosis in 20 million AstraZeneca vaccines administered. The president of the Superior Health Council Locatelli explains this in a press conference to the Ministry of Health, explaining: “There is no evidence that the AstraZeneca, which covers 100% for severe forms of Covid-19, increases the risk of thromboembolic complications “. He is echoed by the general manager Aifa Magrini who explains how to date there is no causal link between vaccination and thrombotic events.

Locatelli then specifies that “Covid infection is much more dangerous” and that even in the 25 recorded cases of thromboembolism a causal link with the vaccine is “not demonstrable”. For this reason, explains the general director of Prevention of the Ministry of Health Giovanni Rezza, vaccinations with AstraZeneca must resume: «Before the vaccine was blocked we had reached a rate of 200 thousand vaccinations per day. Now we have to at least double that figure“. Rezza himself stressed that the revocation of the suspension of the vaccine is “a great relief” because curbing the vaccination campaign now would be “extremely risky”.


There will be no changes to vaccination procedures, he explains later, even if “we asked to update the part concerning informed consent, not only as regards AstraZeneca but also to make it more agile ». The goal, explains Rezza, is to vaccinate 400-500 thousand people a day. And compared to the hypothesis that those who refuse the AstraZeneca vaccine then end up at the bottom of the vaccination list, the president of the Css Locatelli always clarifies, explaining that if a person is called and refuses to get vaccinated with AstraZeneca “they will be considered for other types of vaccines later in time”.

After the green light of the EMA which restarts the administration of the vaccine also in Italy, the Aifa will also express itself in the coming days to advise against the preventive use of drugs such as aspirin or heparin, for those waiting to receive the AstraZeneca vaccine. “There is no reason to use preventive or post-vaccination medications because there is no proven link. There are no indications even for women who use the pill “ explains the director Aifa Nicola Magrini who then turns to those who have already received the vaccination: “People vaccinated with AstraZeneca need to rest assured and to be among the “privileged” party that has already been immunized and made safe “.

THE ASTRAZENECA CASE: THE LATEST UPDATES

March 19, 2021 (change March 19, 2021 | 15:50)

© Time.News

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.